Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Zhenkun Huang
Observed name:
Huang, Zhenkun
Institutions:
Sun Yat-sen University Cancer Center,
State Key Laboratory of Oncology in South China
Observed institutions:
Sun Yat-sen University Cancer Center,
State Key Laboratory of Oncology in South China
ORCID:
0009-0000-3994-703X
Observed ORCID:
0009-0000-3994-703X
OpenAlex ID:
A5149106135
HSPA6 Confers Lenvatinib Resistance in Hepatocellular Carcinoma by Promoting Phase Separation–Mediated TXNRD1 Stabilization to Suppress Ferroptosis
2026
·
Yi Zeng
, Zhenkun Huang
, et al.
·
Cancer Research
·
2
Data from HSPA6 Confers Lenvatinib Resistance in Hepatocellular Carcinoma by Promoting Phase Separation–Mediated TXNRD1 Stabilization to Suppress Ferroptosis
2026
·
Yi Zeng
, Zhenkun Huang
, et al.
·
1
Supplementary Fig. 5 from HSPA6 Confers Lenvatinib Resistance in Hepatocellular Carcinoma by Promoting Phase Separation–Mediated TXNRD1 Stabilization to Suppress Ferroptosis
2026
·
Yi Zeng
, Zhenkun Huang
, et al.
Supplementary Fig. 6 from HSPA6 Confers Lenvatinib Resistance in Hepatocellular Carcinoma by Promoting Phase Separation–Mediated TXNRD1 Stabilization to Suppress Ferroptosis
2026
·
Yi Zeng
, Zhenkun Huang
, et al.
Supplementary Table 5 from HSPA6 Confers Lenvatinib Resistance in Hepatocellular Carcinoma by Promoting Phase Separation–Mediated TXNRD1 Stabilization to Suppress Ferroptosis
2026
·
Yi Zeng
, Zhenkun Huang
, et al.
Supplementary Table 9 from HSPA6 Confers Lenvatinib Resistance in Hepatocellular Carcinoma by Promoting Phase Separation–Mediated TXNRD1 Stabilization to Suppress Ferroptosis
2026
·
Yi Zeng
, Zhenkun Huang
, et al.
Supplementary Fig. 4 from HSPA6 Confers Lenvatinib Resistance in Hepatocellular Carcinoma by Promoting Phase Separation–Mediated TXNRD1 Stabilization to Suppress Ferroptosis
2026
·
Yi Zeng
, Zhenkun Huang
, et al.
Supplementary Fig. 3 from HSPA6 Confers Lenvatinib Resistance in Hepatocellular Carcinoma by Promoting Phase Separation–Mediated TXNRD1 Stabilization to Suppress Ferroptosis
2026
·
Yi Zeng
, Zhenkun Huang
, et al.
Supplementary Table 8 from HSPA6 Confers Lenvatinib Resistance in Hepatocellular Carcinoma by Promoting Phase Separation–Mediated TXNRD1 Stabilization to Suppress Ferroptosis
2026
·
Yi Zeng
, Zhenkun Huang
, et al.
Supplementary Table 6 from HSPA6 Confers Lenvatinib Resistance in Hepatocellular Carcinoma by Promoting Phase Separation–Mediated TXNRD1 Stabilization to Suppress Ferroptosis
2026
·
Yi Zeng
, Zhenkun Huang
, et al.
Supplementary Fig. 7 from HSPA6 Confers Lenvatinib Resistance in Hepatocellular Carcinoma by Promoting Phase Separation–Mediated TXNRD1 Stabilization to Suppress Ferroptosis
2026
·
Yi Zeng
, Zhenkun Huang
, et al.
Supplementary Table 3 from HSPA6 Confers Lenvatinib Resistance in Hepatocellular Carcinoma by Promoting Phase Separation–Mediated TXNRD1 Stabilization to Suppress Ferroptosis
2026
·
Yi Zeng
, Zhenkun Huang
, et al.
Supplementary Table 1 from HSPA6 Confers Lenvatinib Resistance in Hepatocellular Carcinoma by Promoting Phase Separation–Mediated TXNRD1 Stabilization to Suppress Ferroptosis
2026
·
Yi Zeng
, Zhenkun Huang
, et al.
Supplementary Fig. 2 from HSPA6 Confers Lenvatinib Resistance in Hepatocellular Carcinoma by Promoting Phase Separation–Mediated TXNRD1 Stabilization to Suppress Ferroptosis
2026
·
Yi Zeng
, Zhenkun Huang
, et al.
Supplementary Table 7 from HSPA6 Confers Lenvatinib Resistance in Hepatocellular Carcinoma by Promoting Phase Separation–Mediated TXNRD1 Stabilization to Suppress Ferroptosis
2026
·
Yi Zeng
, Zhenkun Huang
, et al.
Supplementary Table 10 from HSPA6 Confers Lenvatinib Resistance in Hepatocellular Carcinoma by Promoting Phase Separation–Mediated TXNRD1 Stabilization to Suppress Ferroptosis
2026
·
Yi Zeng
, Zhenkun Huang
, et al.
Supplementary Table 4 from HSPA6 Confers Lenvatinib Resistance in Hepatocellular Carcinoma by Promoting Phase Separation–Mediated TXNRD1 Stabilization to Suppress Ferroptosis
2026
·
Yi Zeng
, Zhenkun Huang
, et al.
Supplementary Table 2 from HSPA6 Confers Lenvatinib Resistance in Hepatocellular Carcinoma by Promoting Phase Separation–Mediated TXNRD1 Stabilization to Suppress Ferroptosis
2026
·
Yi Zeng
, Zhenkun Huang
, et al.
Supplementary Fig. 1 from HSPA6 Confers Lenvatinib Resistance in Hepatocellular Carcinoma by Promoting Phase Separation–Mediated TXNRD1 Stabilization to Suppress Ferroptosis
2026
·
Yi Zeng
, Zhenkun Huang
, et al.
Supplementary Fig. 8 from HSPA6 Confers Lenvatinib Resistance in Hepatocellular Carcinoma by Promoting Phase Separation–Mediated TXNRD1 Stabilization to Suppress Ferroptosis
2026
·
Yi Zeng
, Zhenkun Huang
, et al.
Show more works
View as search
Works count:
31
Citation count:
3
H-index:
1
I10-index:
Year
Topic
Type